BREVIBLOC IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Brevibloc In Plastic Container patents expire, and when can generic versions of Brevibloc In Plastic Container launch?
Brevibloc In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in BREVIBLOC IN PLASTIC CONTAINER is esmolol hydrochloride. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the esmolol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Brevibloc In Plastic Container
A generic version of BREVIBLOC IN PLASTIC CONTAINER was approved as esmolol hydrochloride by HIKMA on August 10th, 2004.
Summary for BREVIBLOC IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Clinical Trials: | 16 |
Patent Applications: | 703 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BREVIBLOC IN PLASTIC CONTAINER at DailyMed |

Recent Clinical Trials for BREVIBLOC IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Zagazig University | Phase 2 |
Cristália Produtos Químicos Farmacêuticos Ltda. | Phase 4 |
University Hospital Bispebjerg and Frederiksberg | Phase 4 |
Pharmacology for BREVIBLOC IN PLASTIC CONTAINER
Drug Class | beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic beta-Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for BREVIBLOC IN PLASTIC CONTAINER
Paragraph IV (Patent) Challenges for BREVIBLOC IN PLASTIC CONTAINER
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
BREVIBLOC IN PLASTIC CONTAINER | Injection | esmolol hydrochloride | 10 mg/mL, 250 mL infusion bags and 20 mg/mL, 100 mL infusion bags | 019386 | 1 | 2014-01-31 |
US Patents and Regulatory Information for BREVIBLOC IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | BREVIBLOC IN PLASTIC CONTAINER | esmolol hydrochloride | INJECTABLE;INJECTION | 019386-004 | Feb 16, 2001 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BREVIBLOC IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare | BREVIBLOC IN PLASTIC CONTAINER | esmolol hydrochloride | INJECTABLE;INJECTION | 019386-004 | Feb 16, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Baxter Hlthcare | BREVIBLOC IN PLASTIC CONTAINER | esmolol hydrochloride | INJECTABLE;INJECTION | 019386-004 | Feb 16, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Baxter Hlthcare | BREVIBLOC IN PLASTIC CONTAINER | esmolol hydrochloride | INJECTABLE;INJECTION | 019386-004 | Feb 16, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BREVIBLOC IN PLASTIC CONTAINER
See the table below for patents covering BREVIBLOC IN PLASTIC CONTAINER around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2272720 | ⤷ Try a Trial | |
China | 1455669 | ⤷ Try a Trial | |
Australia | 4150785 | ⤷ Try a Trial | |
Hungary | 0204520 | ⤷ Try a Trial | |
Poland | 216192 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |